Identifying the type of depression present in an individual with or at-risk for symptomatic knee osteoarthritis can help clinicians best target therapies to reduce pain and disability over time, according to a new study.
Whitney J. Palmer
Adding acupuncture to topical ibuprofen can provide greater pain relief for patients with osteoarthritis who have chronic knee pain than treating them with only topical ibuprofen, according to recent research.
Patients with giant cell arteritis treated weekly or bi-weekly with tocilizumab and a prednisone taper experience better outcomes than those treated only with prednisone, a new study shows.
Patients affected by psoriatic arthritis may benefit from both pharmacologic and non-pharmacologic treatments. In this slideshow, we outline the recommendations from the ACR and the National Psoriasis Foundation.
Osteoarthritis patients over age 50 could face a greater risk of mortality after receiving an initial tramadol prescription compared to various commonly prescribed NSAIDS, according to new research.
Rheumatoid arthritis patients and rheumatology providers share many of the same concerns over obstacles that make it harder to reach treat-to-target goals, according to a new study.
Osteoarthritis and rheumatoid arthritis patients report having similar pain levels in the beginning, but by six months, osteoarthritis patients say their pain is worse. This suggests a need for more effective osteoarthritis treatments, say researchers writing in Arthritis & Rheumatology. In this Q&A, the study’s lead author, Theodore Pincus, M.D., of Rush University Medical Center in Chicago, shares his findings with us.
A new systematic review and meta-analysis shows that while NSAIDs peaks at two weeks, while gastrointestinal and cardiovascular adverse events linger.
To help clinicians provide guidance to patients interested in cannabis therapies, the Canadian Rheumatology Association has issued a position statement. In this slideshow, we highlight the recommendations.
Study shows there is no substantial difference in cardiovascular risk associated with different biologic therapies for psoriasis and psoriatic arthritis patients.